---
title: "Karyopharm Therap (KPTI.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/KPTI.US/norm.md"
symbol: "KPTI.US"
name: "Karyopharm Therap"
parent: "https://longbridge.com/en/quote/KPTI.US.md"
datetime: "2026-05-21T21:39:38.629Z"
locales:
  - [en](https://longbridge.com/en/quote/KPTI.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/KPTI.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/KPTI.US/norm.md)
---

# Karyopharm Therap (KPTI.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| EPS | -1.24 | -5.71 | -3.82 | -4.32 | -2.77 |
| ROE | 32.07% | 145.43% | 52.15% | 67.00% | 47.89% |
| Revenue | 35.07M | 34.08M | 44.04M | 37.93M | 30.02M |
| Net income | -22.39M | -102.20M | -33.13M | -37.25M | -23.46M |
| Operating income | -26.76M | -17.84M | -15.22M | -24.39M | -33.26M |
| Gross margin | 96.16% | 14.46% | 25.85% | 10.78% | -19.67% |
| Net margin | -63.86% | -299.89% | -75.21% | -98.22% | -78.17% |
| Profit quality | - | - | - | - | - |

## Balance Sheet (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| A&L | 131.42M | 108.42M | 96.23M | 104.88M | 127.71M |
| Leverage | -0.4947 | -0.3701 | -0.3574 | -0.4390 | -0.6203 |
| BVPS | -12.07 | -16.00 | -30.94 | -27.63 | -24.03 |
| Turnover | 1.17 | 1.07 | 0.9977 | 0.8610 | 0.8557 |
| Cash & STI | 90.85M | 63.74M | 45.88M | 51.70M | 69.94M |
| Inv & Rec | - | 4.04M | 3.97M | 4.99M | 4.77M |
| LT assets | - | 4.65M | 4.80M | 5.33M | 5.80M |
| Net debt | 205.88M | 242.20M | 224.04M | 212.42M | 190.26M |

## Cash Flow Statement (USD)

| Indicator | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | - | -11.83M | -5.86M | -18.70M | -38.98M |
| Investing CF | - | 5.00M | 4.80M | 18.29M | 15.29M |
| Financing CF | - | 29.69M | 0.0000 | 356000.00 | - |
| Free CF | - | -6.17M | 2.10M | -5.14M | -22.08M |
| OCF coverage | - | -4731.20% | - | - | - |
| Repaid & issued | - | 27.25M | - | - | - |
| CapEx | - | - | - | - | - |